Interventions for valvular disease and heart failure

Single-access balloon aortic valvuloplasty – an overview of contemporary technical improvements

EuroIntervention 2019;15:e766-e770. DOI: 10.4244/EIJ-D-19-00074

Joris Ooms
Joris F.W. Ooms1, MD; Maarten van Wiechen1, MD; Francesca Ziviello1, MD; Herbert Kroon1, MD; Ben Ren1, MD, PhD; Joost Daemen1, MD, PhD; Peter De Jaegere1, MD, PhD; Nicolas M. Van Mieghem1, MD, PhD
1. Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands


Balloon aortic valvuloplasty (BAV) was originally devised as an alternative approach for treating aortic valve stenosis (AS) in patients who could not undergo aortic valve replacement (AVR)1. However, BAV only provided temporary clinical and haemodynamic improvement and its use was therefore limited to palliative therapy2. Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of symptomatic severe AS in elderly patients with an elevated operative risk3. Treating this increasingly frail population has renewed interest in a therapy which could temporarily alleviate symptoms in order to bridge patients to definitive valve replacement therapy or other urgent therapy.


Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for valvular diseaseOther valvular and structural interventions
Read next article
Characteristics and significance of healed plaques in patients with acute coronary syndrome and stable angina: an in vivo OCT and IVUS study

Latest news